Results 261 to 270 of about 41,675 (347)

AI‐Assisted Decision‐Making for End‐Stage Organ Failure: Opportunities and Ethical Concerns

Artificial Organs, EarlyView.
Artificial intelligence (AI) can help physicians make better decisions for people with serious organ problems by analyzing medical data to predict outcomes. Patients want AI to support, not replace, personal care from doctors. Collaboration among experts ensures AI tools respect patient values and privacy.
John W. Haller, Olga D. Brazhnik, Kathleen N. Fenton   +2 more
wiley   +1 more source

Outcomes Associated with Protekduo Right Ventricular Assist Device [PDF]

M. Atienza, Ulrich P. Jorde, D. Goldstein, Omar Saeed, S. Vukelic, Snehal R. Patel, S. Murthy, Mayuko Uehara, S. Forest, J. Borgi, Daniel B. Sims   +10 more
openalex   +1 more source

Hydraulic In Vitro Characterization of MR‐Conditional Blood Pumps

Artificial Organs, EarlyView.
Cardiac surgery in neonates requires close placement of cardiopulmonary bypass machines due to limited blood volume, complicating MR compatibility. This study introduces three MR‐conditional blood pump prototypes. None interfered with MRI imaging, though RF‐related sensor effects remain untested.
Dominik T. Schulte, Marcel Renggli, Henning Richter, Francesca Del Chicca, Michael Hofmann, Martin O. Schmiady, Marianne Schmid Daners   +6 more
wiley   +1 more source

Critical care management of right ventricular failure in pediatric left ventricular assist devices: An advanced cardiac therapies improving outcomes network (ACTION) endorsed statement [PDF]

Edon J. Rabinowitz, Nancy S. Ghanayem, Lydia Wright, Amee M. Bigelow, Shilpa Vellore Govardhan, Tara M. Neumayr, Tanya Perry, Meghna D. Patel, Robert A. Niebler, K. Engelhardt, Isaura Diaz, Joseph Philip, Arene Butto, Iki Adachi, David M. Peng, Sebastian C. Tume, Sebastian C. Tume   +16 more
openalex   +1 more source

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

A leadless pacemaker implantation for a patient with systemic right ventricle under ventricular assist device support [PDF]

Kohsaku Goto, Toshiya Kojima, Tsukasa Oshima, Akihito Saito, Yu Shimizu, Katsura Soma, Yukiteru Nakayama, Eriko Hasumi, Ryo Inuzuka, Masahiko Ando, Eisuke Amiya, Katsuhito Fujiu, Yasutaka Hirata, Masaru Hatano, Minoru Ōno, Issei Komuro   +15 more
openalex   +1 more source

A Novel Biventricular Assist Device With a Single Driveline: A Report on the First Patient Treated

Artificial Organs, EarlyView.
We would like to report the first‐in‐human implantation of the novel DuoCor‐BiVAS biventricular assist device (BiVAD). This system features a single driveline and compact peripheral components, offering a promising mechanical support option for patients with terminal biventricular heart failure ineligible for heart transplantation.
Jan D. Schmitto, Jasmin S. Hanke, Sara Knigge, Zurab Darbaidze, Fanwu Kong, Torsten Heilmann, Alexander Weymann, Günes Dogan, Arjang Ruhparwar   +8 more
wiley   +1 more source

Single‐Incision Anterolateral Thoracotomy for LVAD Implantation: A Novel Minimally Invasive Approach

Artificial Organs, EarlyView.
A novel single‐incision anterolateral thoracotomy technique enables complete HeartMate 3 implantation without sternotomy, minimizing surgical trauma and accelerating recovery. This minimally invasive approach is feasible, safe, and may represent a new standard in advanced heart failure surgery.
Ali Saad Merzah, Günes Dogan, Alina Zubarevich, Stefan Rümke, Bastian Schmack, Ezin Deniz, Jasmin Hanke, Arjang Ruhparwar, Jan D. Schmitto, Alexander Weymann   +9 more
wiley   +1 more source

The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta‐Analysis

Artificial Organs, EarlyView.
14 100 LVAD patients across 21 studies were analyzed. Findings indicated that obese LVAD recipients had lower short‐term mortality and higher risk of infection, thrombosis and right heart failure. There was no difference in long‐term survival between obese and non‐obese patients.
Hugh Jacobs, Olivia Frost, Arian Arjomandi Rad, Wing Kiu Chou, Sadeq Al‐Saegh, Alina Zubarevich, Alexander Weymann, Arjang Ruhparwar, Lukman Amanov, Peyman Sardari Nia, Antonios Kourliouros, Thanos Athanasiou   +11 more
wiley   +1 more source

Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen‐Year Longitudinal Profile

Artificial Organs, EarlyView.
Our study of 1026 LVAD implants revealed HeartWare had lower driveline infection rates than other LVAD types. In addition, severe diabetes was associated with higher risk, while older age and coronary artery disease were linked to a lower risk of driveline infections.
Anh Nguyen, Alexis Shafii, Gabriel Loor, Andrew Civitello, O. Howard Frazier, Todd Rosengart, Kenneth Liao   +6 more
wiley   +1 more source